GS1 Healthcare Executive Dialogues
Securing trust in the global COVID-19 supply chain
GS1 Executive Dialogue about safety and trust in the global COVID-19 supply chain. As we witness the enormous challenges to deliver and administer vaccines around the planet, key healthcare stakeholders need to act together to make vaccination a global success.
The focus of the Executive Dialogues have been COVID and COVID vaccine-related activities – the first talking about Policy, the second was more focussed on projects related to managing COVID and ongoing works about developing a verification system to reduce the risk from falsified and diverted Covid-19 Vaccine. The third edition covered greater details of the experience around the world in managing the complex supply chain through to the patient administration process, to reduce the risk from falsified and diverted Covid-19 Vaccines.
Senior executives discussed ongoing works about developing a verification system in digital healthcare to reduce the risk from falsified and diverted COVID-19 vaccines and to improve identification at the point of care.
For more information, don't hesitate to contact us
GS1 Collaboration
In this difficult time GS1 worked relentlessly to transform this crisis into an opportunity for humanity, working together with partners to address our common challenge in a proactive and constructive manner. In this light, GS1 had the pleasure to collaborate with Deloitte on the distribution of the white paper named “Securing trust in the global COVID-19 supply chain”.
Join the conversation and make sure to attend future Executive Dialogues!
Follow us on Twitter: #GS1Healthcare and LinkedIn